𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment

✍ Scribed by V. A. Holthoff; K. Herholz; F. Berthold; B. Widemann; R. Schröder; I. Neubauer; W. D. Heiss

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
990 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy for medulloblastoma/primiti
Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa
✍ Dr Roger J. Packer 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

## Abstract Chemotherapy has only marginal efficacy in adult malignant brain tumors. In contrast, drug therapy is considerably more effective in medulloblastoma/primitive neuroectodermal tumors (MB/PNET) of the posterior fossa, the most common childhood primary central nervous system tumor. At the

Vasoactive intestinal peptide (VIP) and
Vasoactive intestinal peptide (VIP) and VIP receptors: Gene expression and growth modulation in medulloblastoma and other central primitive neuroectodermal tumors of childhood
✍ Michael C. Frühwald; M. Sue O'Dorisio; Julie Fleitz; Torsten Pietsch; Jean Claud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 2 views

Vasoactive intestinal peptide (VIP) is a neuromodulator and growth regulator in the developing nervous system. We analyzed 10 primitive neuroectodermal tumor (PNET) cell lines, 29 central PNET (cPNET) and 17 tumors of the Ewing's sarcoma/peripheral PNET family (ESFT) using reverse transcriptase-poly